Metformin in COVID-19: a possible role beyond diabetes S Sharma, A Ray, B Sadasivam Diabetes research and clinical practice 164, 108183, 2020 | 213 | 2020 |
Evidence for the involvement of the monoaminergic system, but not the opioid system in the antidepressant-like activity of ellagic acid in mice C Girish, V Raj, J Arya, S Balakrishnan European Journal of Pharmacology 682 (1-3), 118-125, 2012 | 112 | 2012 |
Involvement of the GABAergic system in the anxiolytic-like effect of the flavonoid ellagic acid in mice C Girish, V Raj, J Arya, S Balakrishnan European Journal of Pharmacology 710 (1-3), 49-58, 2013 | 90 | 2013 |
Role of nitric oxide in electroshock and pentylenetetrazole G Nidhi, S Balakrishnan, P Pandhi Methods Find Exp Clin Pharmacol 21 (9), 609-612, 1999 | 76 | 1999 |
Effect of nimodipine on the efficacy of commonly used antiepileptic drugs in rats. S Balakrishnan, P Pandhi, VK Bhargava Indian journal of experimental biology 36 (1), 51-54, 1998 | 45 | 1998 |
Fixed-drug eruptions: What can we learn from a case series? R Jhaj, D Chaudhary, D Asati, B Sadasivam Indian journal of dermatology 63 (4), 332-337, 2018 | 43 | 2018 |
Ellagic acid modulates sodium valproate induced reproductive toxicity in male Wistar rats C Girish, O Shweta, V Raj, S Balakrishnan, RG Varghese Indian J Physiol Pharmacol 58 (4), 416-422, 2014 | 40 | 2014 |
A comparative experimental study of analgesic activity of a novel non-steroidal anti-inflammatory molecule–zaltoprofen, and a standard drug–piroxicam, using murine models C Santenna, S Kumar, S Balakrishnan, R Jhaj, SN Ahmed Journal of Experimental Pharmacology, 85-91, 2019 | 38 | 2019 |
Diabetes care during COVID-19 lockdown at a tertiary care centre in India R Joshi, S Atal, Z Fatima, S Balakrishnan, S Sharma, A Joshi diabetes research and clinical practice 166, 108316, 2020 | 36 | 2020 |
A cost variation analysis of drugs available in the Indian market for the management of thromboembolic disorders A Ray, A Najmi, G Khandelwal, B Sadasivam Cureus 12 (5), 2020 | 32 | 2020 |
Approval of itolizumab for COVID-19: a premature decision or need of the hour? S Atal, Z Fatima, S Balakrishnan BioDrugs 34 (6), 705-711, 2020 | 27 | 2020 |
The safety, tolerability and mortality reduction efficacy of remdesivir; based on randomized clinical trials, observational and case studies reported safety outcomes: an … C Santenna, K Vidyasagar, KC Amarneni, SN Ghanta, B Sadasivam, ... Therapeutic Advances in Drug Safety 12, 20420986211042517, 2021 | 26 | 2021 |
The potential therapeutic role of proton pump inhibitors in COVID-19: hypotheses based on existing evidences A Ray, S Sharma, B Sadasivam Drug Research 70 (10), 484-488, 2020 | 26 | 2020 |
Anticonvulsant profile of ondansetron in rats S Balakrishnan, VK Bhargava, P Pandhi Epilepsy & Behavior 1 (1), 22-26, 2000 | 24 | 2000 |
Ceftaroline fosamil: A novel anti-Methicillin-resistant Staphylococcus aureus cephalosporin C Girish, S Balakrishnan Journal of Pharmacology and Pharmacotherapeutics 2 (3), 209-211, 2011 | 22 | 2011 |
Medication concordance in modern medicine–A critical appraisal from an Indian perspective S Atal, B Sadasivam, SN Ahmed, A Ray Journal of family medicine and primary care 8 (4), 1313-1318, 2019 | 21 | 2019 |
A randomized parallel trial of topical aspirin–moisturizer solution vs. oral aspirin for acute herpetic neuralgia S Balakrishnan, K Bhushan, VK Bhargava, P Pandhi International journal of dermatology 40 (8), 535-538, 2001 | 21 | 2001 |
An observational multi-centric COVID-19 sequelae study among health care workers AK Shukla, S Atal, A Banerjee, R Jhaj, S Balakrishnan, PK Chugh, ... The Lancet Regional Health-Southeast Asia 10, 2023 | 19 | 2023 |
Knowledge, attitude, and practice survey on antimicrobial use and resistance among Indian clinicians: A multicentric, cross-sectional study S Chatterjee, A Hazra, R Chakraverty, N Shafiq, A Pathak, N Trivedi, ... Perspectives in clinical research 13 (2), 99-105, 2022 | 19 | 2022 |
Famotidine repurposing for novel corona virus disease of 2019: a systematic review S Chenchula, A Ray, B Sadasivam Drug Research 71 (06), 295-301, 2021 | 19 | 2021 |